BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24324152)

  • 1. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination.
    Vono M; Taccone M; Caccin P; Gallotta M; Donvito G; Falzoni S; Palmieri E; Pallaoro M; Rappuoli R; Di Virgilio F; De Gregorio E; Montecucco C; Seubert A
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21095-100. PubMed ID: 24324152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
    Caproni E; Tritto E; Cortese M; Muzzi A; Mosca F; Monaci E; Baudner B; Seubert A; De Gregorio E
    J Immunol; 2012 Apr; 188(7):3088-98. PubMed ID: 22351935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.
    Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A
    Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinically applicable adjuvant for an atherosclerosis vaccine in mice.
    Kobiyama K; Vassallo M; Mitzi J; Winkels H; Pei H; Kimura T; Miller J; Wolf D; Ley K
    Eur J Immunol; 2018 Sep; 48(9):1580-1587. PubMed ID: 29932463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.
    Seubert A; Calabro S; Santini L; Galli B; Genovese A; Valentini S; Aprea S; Colaprico A; D'Oro U; Giuliani MM; Pallaoro M; Pizza M; O'Hagan DT; Wack A; Rappuoli R; De Gregorio E
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11169-74. PubMed ID: 21690334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen.
    Jiao XD; Cheng S; Hu YH; Sun L
    Vaccine; 2010 Feb; 28(7):1832-7. PubMed ID: 20006568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells.
    Seubert A; Monaci E; Pizza M; O'Hagan DT; Wack A
    J Immunol; 2008 Apr; 180(8):5402-12. PubMed ID: 18390722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.
    Calabro S; Tortoli M; Baudner BC; Pacitto A; Cortese M; O'Hagan DT; De Gregorio E; Seubert A; Wack A
    Vaccine; 2011 Feb; 29(9):1812-23. PubMed ID: 21215831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.
    Ko EJ; Lee YT; Kim KH; Jung YJ; Lee Y; Denning TL; Kang SM
    J Virol; 2016 Aug; 90(15):6976-6988. PubMed ID: 27226368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology and efficacy of MF59-adjuvanted vaccines.
    Ko EJ; Kang SM
    Hum Vaccin Immunother; 2018; 14(12):3041-3045. PubMed ID: 30015572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice.
    Higgins DA; Carlson JR; Van Nest G
    Vaccine; 1996 Apr; 14(6):478-84. PubMed ID: 8782343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
    Della Cioppa G; Nicolay U; Lindert K; Leroux-Roels G; Clement F; Castellino F; Galli G; Groth N; Del Giudice G
    Hum Vaccin Immunother; 2012 Feb; 8(2):216-27. PubMed ID: 22426371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life.
    Mastelic Gavillet B; Eberhardt CS; Auderset F; Castellino F; Seubert A; Tregoning JS; Lambert PH; de Gregorio E; Del Giudice G; Siegrist CA
    J Immunol; 2015 May; 194(10):4836-45. PubMed ID: 25870238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
    Galli G; Hancock K; Hoschler K; DeVos J; Praus M; Bardelli M; Malzone C; Castellino F; Gentile C; McNally T; Del Giudice G; Banzhoff A; Brauer V; Montomoli E; Zambon M; Katz J; Nicholson K; Stephenson I
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7962-7. PubMed ID: 19416838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
    Valensi JP; Carlson JR; Van Nest GA
    J Immunol; 1994 Nov; 153(9):4029-39. PubMed ID: 7930610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
    Banzhoff A; Pellegrini M; Del Giudice G; Fragapane E; Groth N; Podda A
    Influenza Other Respir Viruses; 2008 Nov; 2(6):243-9. PubMed ID: 19453401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
    Cioncada R; Maddaluno M; Vo HTM; Woodruff M; Tavarini S; Sammicheli C; Tortoli M; Pezzicoli A; De Gregorio E; Carroll MC; D'Oro U; Piccioli D
    PLoS One; 2017; 12(10):e0185843. PubMed ID: 29088224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.